A PROSPECTIVE PHASE II STUDY OF INDUCTION ERLOTINIB THERAPY IN STAGE IIIA-N2 NON-SMALL-CELL LUNG CANCER

被引：0
|
作者：
Zhong, W. -Z.
Yang, X. -N.
Liao, R. -Q.
Nie, Q.
Su, J.
Zhang, X. -C.
An, S. -J.
Zhou, Q.
Yang, J. -J.
Wu, Y. -L.
机构：
[1] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[2] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [21] Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer
    Lopez, S.
    CANCER RADIOTHERAPIE, 2008, 12 (05): : 500 - 501
  • [22] Role of surgery for stage IIIA-N2 non-small cell lung cancer
    Yang, Fan
    Wang, Jun
    THORACIC CANCER, 2011, 2 (03) : 90 - 94
  • [23] Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: A review
    Vansteenkiste, J
    De Leyn, P
    Deneffe, G
    Menten, J
    Lerut, T
    Demedts, M
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1998, 13 (01) : 1 - 12
  • [24] Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer
    De Marinis, Filippo
    Gebbia, V.
    De Petris, L.
    ANNALS OF ONCOLOGY, 2005, 16 : 116 - 122
  • [25] Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study
    Zhong, Wen-Zhao
    Chen, Ke-Neng
    Chen, Chun
    Gu, Chun-Dong
    Wang, Jun
    Yang, Xue-Ning
    Mao, Wei-Min
    Wang, Qun
    Qiao, Gui-Bin
    Cheng, Ying
    Xu, Lin
    Wang, Chang-Li
    Chen, Ming-Wei
    Kang, Xiaozheng
    Yan, Wanpu
    Yan, Hong-Hong
    Liao, Ri-Qiang
    Yang, Jin-Ji
    Zhang, Xu-Chao
    Zhou, Qing
    Wu, Yi-Long
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (25) : 2235 - +
  • [26] Multimodality therapy in stage IIIA non-small-cell lung cancer
    Kim, SY
    Lee, YS
    Jung, SS
    Yun, WJ
    Kim, JO
    Cho, MJ
    Lim, SR
    Kim, JS
    Roh, YH
    LUNG CANCER, 2004, 45 : S57 - S58
  • [27] Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
    Pless, Miklos
    Stupp, Roger
    Ris, Hans-Beat
    Stahel, Rolf A.
    Weder, Walter
    Thierstein, Sandra
    Gerard, Marie-Aline
    Xyrafas, Alexandros
    Frueh, Martin
    Cathomas, Richard
    Zippelius, Alfred
    Roth, Arnaud
    Bijelovic, Milorad
    Ochsenbein, Adrian
    Meier, Urs R.
    Mamot, Christoph
    Rauch, Daniel
    Gautschi, Oliver
    Betticher, Daniel C.
    Mirimanoff, Rene-Olivier
    Peters, Solange
    LANCET, 2015, 386 (9998): : 1049 - 1056
  • [28] Resectable IIIA-N2 Non-Small-Cell Lung Cancer (NSCLC): In Search for the Proper Treatment
    Brascia, Debora
    De Iaco, Giulia
    Schiavone, Marcella
    Panza, Teodora
    Signore, Francesca
    Geronimo, Alessandro
    Sampietro, Doroty
    Montrone, Michele
    Galetta, Domenico
    Marulli, Giuseppe
    CANCERS, 2020, 12 (08) : 1 - 31
  • [29] Effects of Neoadjuvant Radiotherapy on Survival in Patients with Stage IIIA-N2 Non-Small-Cell Lung Cancer Following Pneumonectomy
    Qu, Chenghao
    Li, Rongyang
    Han, Jingyi
    Yue, Weiming
    Tian, Hui
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [30] Risk Associated with Bilobectomy after Neoadjuvant Concurrent Chemoradiotherapy for Stage IIIA-N2 Non-small-cell Lung Cancer
    Jong Ho Cho
    Jhingook Kim
    Kwhanmien Kim
    Young Mog Shim
    Hong Kwan Kim
    Yong Soo Choi
    World Journal of Surgery, 2012, 36 : 1199 - 1205
12345